Marina Biotech, Inc.  

(Public, OTCMKTS:MRNA)   Watch this stock  
Find more results for NASDAQ:MRNA
-0.009 (-8.09%)
Oct 21 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.09 - 0.11
52 week 0.08 - 0.52
Open 0.10
Vol / Avg. 73,134.00/66,887.00
Mkt cap 3.09M
P/E 1.70
Div/yield     -
EPS 0.06
Shares 29.76M
Beta -0.27
Inst. own 0%
Aug 12, 2016
Q2 2016 Marina Biotech Inc Earnings Release (Estimated)

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin - 490.74%
Operating margin - -583.97%
EBITD margin - -586.62%
Return on average assets -36.01% 39.70%
Return on average equity -201.41% -
Employees 1 -
CDP Score - -


3830 Monte Villa Pkwy
BOTHELL, WA 98021-7266
United States - Map
+1-425-9083600 (Phone)
+1-302-6745266 (Fax)

Website links


Marina Biotech, Inc. is a biotechnology company focused on the discovery, development and commercialization of nucleic acid-based therapies to treat orphan diseases. The Company's pipeline includes CEQ508, a product in clinical development for the treatment of Familial Adenomatous Polyposis (FAP), and preclinical programs for the treatment of type 1 myotonic dystrophy (DM1) and Duchenne muscular dystrophy (DMD). It creates a range of therapeutics targeting coding and non-coding ribonucleic acid (RNA) through several mechanisms of action, such as RNA interference (RNAi), messenger RNA translational inhibition, exon skipping, microRNA (miRNA) replacement, miRNA inhibition and steric blocking in order to modulate gene expression either up or down depending on the specific mechanism of action. It has two liposomal-based delivery platforms: SMARTICLES, and the platform, which utilizes amino-based liposomal delivery technology and incorporates a molecule, Di-Alkylated Amino Acid (DiLA2).

Officers and directors

Joseph W. Ramelli Chairman of the Board, Acting Chief Executive Officer
Age: 46
Daniel E. Geffken CPA Interim Chief Financial Officer
Age: 58
Stefan D. Loren Ph.D. Lead Independent Director
Age: 51
Philip C. Ranker Director
Age: 54
Trading Activity - Yahoo Finance
Donald A. Williams Independent Director
Age: 56